CYH trades 3.0% above Wall Street's consensus target of $2.92.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CYH achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 37 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Community Health Systems, Inc. (CYH) has a Wall Street consensus price target of $2.92, based on estimates from 37 covering analysts. With the stock currently trading at $3.01, this represents a potential downside of -3.0%. The company has a market capitalization of $424M.
Analyst price targets range from a low of $2.50 to a high of $3.25, representing a 26% spread in expectations. The median target of $3.00 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 8 analysts rating the stock as a Buy or Strong Buy,20 rating it Hold, and 9 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CYH trades at a trailing P/E of 0.8x. Analysts expect EPS to grow +48.9% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 THCTenet Healthcare Corporation | $22.1B | $256.44 | $284.77 | +11.0% | Buy | 12.1x | 32 |
 HCAHCA Healthcare, Inc. | $94.5B | $436.48 | $455.19 | +4.3% | Buy | 14.8x | 46 |
 UHSUniversal Health Services, Inc. | $11.0B | $181.39 | $193.00 | +6.4% | Hold | 8.1x | 43 |
 SGRYSurgery Partners, Inc. | $1.9B | $14.56 | $18.00 | +23.6% | Buy | 31.8x | 22 |
 ACHCAcadia Healthcare Company, Inc. | $2.7B | $28.51 | $34.43 | +20.8% | Buy | 18.7x | 25 |
 SEMSelect Medical Holdings Corporation | $2.0B | $16.51 | $16.50 | -0.1% | Hold | 13.5x | 14 |
 ENSGThe Ensign Group, Inc. | $10.2B | $175.46 | $215.00 | +22.5% | Buy | 22.5x | 13 |
 USPHU.S. Physical Therapy, Inc. | $1.3B | $82.65 | $90.00 | +8.9% | Buy | 30.0x | 13 |
 MCKMcKesson Corporation | $105.0B | $880.50 | $953.00 | +8.2% | Buy | 19.7x | 31 |
 CAHCardinal Health, Inc. | $51.8B | $221.27 | $273.22 | +23.5% | Buy | 17.6x | 33 |
Quick answers to the most common questions about buying CYH stock.
Wall Street's consensus price target for CYH is $2.92, -3.0% from its current price of $3.01. The below-market target from 37 analysts suggests limited near-term appreciation.
CYH has a consensus rating of "Hold" based on 37 Wall Street analysts. The rating breakdown is leaning bearish, with 9 Sell/Strong Sell ratings. The consensus 12-month price target of $2.92 implies -3.0% downside from current levels.
CYH's current price is $3.01 with a consensus target of $2.92 (-3.0% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $3.25 for CYH, while the most conservative target is $2.5. The consensus of $2.92 represents the median expectation. These targets typically reflect 12-month expectations.
CYH is heavily covered by Wall Street, with 37 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 20 recommend Hold, and 9 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CYH stock forecast based on 37 Wall Street analysts shows a consensus price target of $2.92, with estimates ranging from $2.5 (bear case) to $3.25 (bull case). The median consensus rating is "Hold".
Analysts are cautious on CYH, with 9 Sell ratings and a price target of $2.92 (-3.0% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CYH analyst price targets range from $2.5 to $3.25, a 26% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $2.92 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.